Biotech Start-up Takes Another Stride Toward Flu Cure

COVIMRO Ltd - the pioneering British biotech start-up, has developed a food-grade compound that is asserting its ability to combat important viruses.

The Covimro™ solution continues to gain traction through successive research efforts conducted at major research institutions. Now, for the first time, Covimro™ demonstrated its efficacy against the flu virus in an animal model study carried out by A-IR Clinical Research and Pharmidex Pharmaceutical Services.

The In Vivo testing analyzed Covimro's antiviral capability against an infection of Influenza A H3N2, a flu variant consistent with the seasonal, non-lethal viruses familiar to humans. Once induced, the control group of mice subjects saw the virus replicate quickly, infiltrating their airways and manifesting in comprehensive weight loss.

Full Press Release: https://pressat.co.uk/releases/biotech-start-up-takes-another-stride-toward-flu-cure-a4971b434ebbaa48a0d5aa72d6e6392a/